Latest Innovations in Cardiovascular Imaging Software
-
20m 45sPart 3 | Session 1 CT Planning for TAVR - Dr Hasan Jilaihawi
-
9m 25sPart 3 | Session 2 CT Planning for TMVR - Dr Torsten Vahl
-
10m 21sPart 3 | Session 4 CT Planning for TTVR – Dr Azeem Latib
-
21m 51sPart 3 | Session 5 CT Planning for LAAO - Dr Jens Erik Nielsen Kudsk
-
6m 33sPart 3 | Session 6 CT Planning for TPVR - Dr Xavier Iriart
-
2m 12sPart 1 | Session 1 Welcome and Introduction
-
15m 41sPart 1 | Session 2 Pressure Wire Measurements and Decision Making in the Cathlab
-
15m 7sPart 1 | Session 3 Role of Angio-derived vFFR and How It Works
-
26m 34sPart 1 | Session 4 Recorded vFFR Live Case
-
13m 20sPart 1 | Session 5 vFFR Validation Pathway – The FAST Series
-
11m 11sPart 1 | Session 6 Outcome Studies angioFFR & vFFR (FASTIII/LIPSIA Strategy)
Medical Imaging within the cardiovascular arena is constantly subject to changes and new innovations. Pie Medical Imaging (PMI) is a software company that strives to be a front runner in this field.
This page gives an overview of PMI’s latest software developments.
The Key Learnings to Be Taken From the Content Herein Are to Understand:
- The role of medical imaging in interventional cardiology
- What is the added value of medical imaging pre-, peri- and post-percutaneous interventions?
- How does medical imaging blend in the healthcare professional’s daily practice?
This Page Is Designed For:
- Interventional cardiologists
- Cardiac Surgeons
- Radiologists
- Paediatric Cardiovascular Surgeons
More from this programme
Faculty Biographies
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.